Review of subcutaneous interferon β-1a, delivered via the electronic self-injection device RebiSmart™, for the treatment of multiple sclerosis. Devonshire VA, Verdun di Cantogno E Ther Deliv. 2011 Nov; 2(11):1455-65. PMID: 22844681. Abstract CommentRecommendBookmarkWatch